CT
Celea TherapeuticsClinical-stage biotech developing deupirfenidone, a deuterated pirfenidone-derived drug for idiopathic pulmonary fibrosis, spun out of PureTech Health.
4 Pulse stories
DF
Drug FarmDrug Farm is a biotech developing AI-designed small-molecule drugs for rare and immune-inflammatory diseases, led by DF-003, a Phase 3 ALPK1 inhibitor for ROSAH syndrome.
2 Pulse stories
Total Raised
$180M
$138M
Celea TherapeuticsDrug Farm
Last ValuationNot disclosed
Biotech
Sector
Biotech
2025
Founded
2015
Boston, MA
HQ
Shanghai, China / New York, NY
Private
Status
Private
Celea Therapeutics investors
RA Capital ManagementLeaps by BayerPureTech Health
Drug Farm investors
Shanghai Pudong Leading Area Investment CenterShanghai Puxing Collaborative Private Equity FundDetong CapitalWuXi AppTecBioVeda China FundYD CapitalBetta CapitalWedo Venture Management
Data from Value Add Pulse coverage and company research — see the full threads for Celea Therapeutics and Drug Farm.